TY - JOUR
T1 - Meta-analyses of cognitive functions in early-treated adults with phenylketonuria
AU - Romani, Cristina
AU - Olson, Andrew
AU - Aitkenhead, Lynne
AU - Baker, Lucy
AU - Patel, Dhanesha
AU - Spronsen, Francjan Van
AU - MacDonald, Anita
AU - Wegberg, Annemiek van
AU - Huijbregts, Stephan
N1 - Copyright © 2022, The Authors. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).
PY - 2022/12
Y1 - 2022/12
N2 - Our study estimated size of impairment for different cognitive functions in early-treated adults with PKU (AwPKU) by combining literature results in a meta-analytic way. We analysed a large set of functions (N=19), each probed by different measures (average=12). Data were extracted from 26 PKU groups and matched controls, with 757 AwPKU contributing 220 measures. Effect sizes (ESs) were computed using Glass' ∆ where differences in performance between clinical/PKU and control groups are standardized using the mean and standard deviation of the control groups. Significance was assessed using 'measures nested within independent PKU groups' as a random factor. The weighted Glass' ∆ was -.44 for all functions taken together, and -.60 for IQ, both highly significant. Separate, significant impairments were found for most functions, but with great variability (ESs from -1.02 to -.18). The most severe impairments were in reasoning, visual-spatial attention speed, sustained attention, visuo-motor control, and flexibility. Effect sizes were larger with speed than accuracy measures, and with visuo-spatial than verbal stimuli. Results show a specific PKU profile that needs consideration when monitoring the disease.
AB - Our study estimated size of impairment for different cognitive functions in early-treated adults with PKU (AwPKU) by combining literature results in a meta-analytic way. We analysed a large set of functions (N=19), each probed by different measures (average=12). Data were extracted from 26 PKU groups and matched controls, with 757 AwPKU contributing 220 measures. Effect sizes (ESs) were computed using Glass' ∆ where differences in performance between clinical/PKU and control groups are standardized using the mean and standard deviation of the control groups. Significance was assessed using 'measures nested within independent PKU groups' as a random factor. The weighted Glass' ∆ was -.44 for all functions taken together, and -.60 for IQ, both highly significant. Separate, significant impairments were found for most functions, but with great variability (ESs from -1.02 to -.18). The most severe impairments were in reasoning, visual-spatial attention speed, sustained attention, visuo-motor control, and flexibility. Effect sizes were larger with speed than accuracy measures, and with visuo-spatial than verbal stimuli. Results show a specific PKU profile that needs consideration when monitoring the disease.
KW - PKU
KW - Patterna of cognitive impairments
KW - Metabolic disease
KW - Executive functions
KW - Memory
KW - Language
KW - Speed and accuracy
KW - Verbal vs Visual
UR - https://www.sciencedirect.com/science/article/pii/S0149763422004146?via%3Dihub
UR - http://www.scopus.com/inward/record.url?scp=85141461788&partnerID=8YFLogxK
U2 - 10.1016/j.neubiorev.2022.104925
DO - 10.1016/j.neubiorev.2022.104925
M3 - Review article
C2 - 36283539
SN - 0149-7634
VL - 143
JO - Neuroscience and Biobehavioral Reviews
JF - Neuroscience and Biobehavioral Reviews
M1 - 104925
ER -